Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

141.03USD
22 Mar 2019
Change (% chg)

$-5.70 (-3.88%)
Prev Close
$146.73
Open
$145.45
Day's High
$146.25
Day's Low
$140.78
Volume
94,729
Avg. Vol
104,802
52-wk High
$147.68
52-wk Low
$101.58

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

03 Oct 2018

UPDATE 1-Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK, Oct 2 The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

03 Oct 2018

Earnings vs. Estimates